Warfarin—an expensive cause of delay in discharge of elective arthroplasty patients

Conclusion Extrapolating, the annual excess cost of delay in discharge for chronically anticoagulated arthroplasty patients in our institution is approximately £200,000. We conclude that substantial financial and resource savings can be made if warfarinisation is undertaken at the community level.
Source: European Orthopaedics and Traumatology - Category: Orthopaedics Source Type: research